Book of abstracts version 5
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Synthesis thiodigalactoside building blocks, towards anticancer<br />
or anti-inflammatory drugs.<br />
Author<br />
Thijs Verdaasdonk<br />
Academy <strong>of</strong> Technology for Health and Environment<br />
Avans Hogeschool, Breda<br />
Universiteit Utrecht<br />
Nishant Sewgobind<br />
Abstract<br />
Between all the proteins galectin is defined by its affinity for β-galactoside. Galectins function intracellularly,<br />
extracellularly and they are involved in a range <strong>of</strong> biological processes. Many <strong>of</strong> these processes are beneficial f or a<br />
person’s health but these proteins also play a role in some pathological processes. Despite all this the exact biological rol e<br />
<strong>of</strong> galectins remains questionable. For further research an inhibitor is needed to be able to conduct experiments with<br />
these galectins. [1] The inhibitor is a thiodigalactoside molecule wherefor the basic building block a β -galactoside namely<br />
3-O-acetyl-1,2;5,6-di-O-isopropylidene-α-D-gul<strong>of</strong>uranose(4) will be synthesized from 1,2,5,6 -diacetone-α-Dgluc<strong>of</strong>uranose(1).<br />
The complete synthesis will be displayed in the table <strong>of</strong> content(figure 1) it consists <strong>of</strong> 3 steps with an<br />
expected con<strong>version</strong> rate <strong>of</strong> 70%. The first step is a oxidation with pyridinium dichromate, this product will be acetylated<br />
with DABCO and acetic anhydride and the final step is a hydrogenation using palladium on carbon. All products are<br />
purified by column chromatography and analysed with TLC, H -NMR and FTIR.[2]<br />
Keywords: Thiodigalactoside, galectin, inhibitor, β-galactoside and Diacetone-D-glucose.<br />
Table <strong>of</strong> content<br />
Figure 1: reaction scheme full synthesis from 1,2,5,6-diacetone-α-D-gluc<strong>of</strong>uranose(1) to 3-O-acetyl-1,2;5,6-di-Oisopropylidene-α-D-gul<strong>of</strong>uranose(4).<br />
[1] S. Karger, „The Role <strong>of</strong> Galectin-3 as a Marker <strong>of</strong> Cancer and inflammation in a stage IV Ovarian Cancer Patient with<br />
Underlying Pro-Inflammatory Comorbidities,” Case reports in oncology, nr. 6, pp. 343 -349, 2013.<br />
[2] H. van Hattum en e. all., „Tuning the Preference <strong>of</strong> Thiodigalactoside- and Lactosamine-Based,” Journal <strong>of</strong> Medicinal<br />
Chemistry, nr. 56, pp. 1350-1354, 2013.<br />
18